Management of Hypotension in Elderly Patients

Introduction to Hypotension Management

Elderly patients, particularly those over 80 years, have a higher risk of orthostatic hypotension and adverse effects from antihypertensive medications, according to the European Society of Cardiology guidelines 1, 2

Nitrates like isosorbide dinitrate can cause significant hypotension in elderly patients due to direct vasodilation 1
Amiodarone can also cause hypotension, especially with IV administration, and its discontinuation should be done cautiously due to its long half-life and potential for arrhythmia recurrence 1

The European Society of Cardiology guidelines recommend discontinuing vasodilators like isosorbide as a priority when managing hypotension in elderly patients 1
If hypotension persists after isosorbide discontinuation, consider dose reduction of amiodarone rather than complete discontinuation 1
For patients with a history of supraventricular tachycardia (SVT), ACE inhibitors like lisinopril can be used as they do not typically exacerbate SVT and may be beneficial in patients with cardiovascular conditions 3, 1, 4

Monitor blood pressure response over 24-48 hours after discontinuing isosorbide, and check blood pressure within 1-2 weeks after medication changes 1
Assess renal function and electrolytes within 1-2 weeks of medication changes, and monitor for orthostatic hypotension by measuring BP in both sitting and standing positions 1, 4
Target blood pressure for patients ≥80 years is suggested to be <150/90 mmHg, with a systolic BP target of 120-129 mmHg if well tolerated, using the "as low as reasonably achievable" (ALARA) principle if not well tolerated 3, 1, 4
Renal function should be assessed before starting therapy, with a reduced initial dose if creatinine clearance is ≤30 mL/min, and electrolyte monitoring, particularly potassium levels, should be performed within 1-2 weeks of initiation 4

The European Society of Cardiology recommends a cautious approach when managing hypertension in elderly patients, considering factors such as advanced age, isolated systolic hypertension, and risk of orthostatic hypotension 3
Initial doses and subsequent dose titration should be more gradual in elderly patients, with a higher risk of undesirable effects in very old and frail subjects 1
The European Society of Cardiology suggests considering a single agent rather than combination therapy in very elderly patients, and preferring fixed-dose single-pill combinations when combination therapy is needed 3